Drug pricing policy stories

Feb 6, 2026

Trump Announces Phased Tariff Plan on Generic Drug Imports: 0% Until 2028, Then 100% and 200%

President Donald Trump announced that imported generic drugs will face no tariffs for two years starting August 1, 2026, after which tariffs will rise to 100% in August 2028 and 200% from 2029 onward. The policy aims to encourage domestic pharmaceutical manufacturing but raises concerns about future drug price increases for consumers.

Feb 6, 20269 sources

Top claims

▪Industry experts warn that the two-year timeline is insufficient for domestic manufacturers to build the specialized infrastructure required to meet United States generic drug demand
▪Sandoz CEO Richard Saynor stated that policymakers and the pharmaceutical industry must work together to create a sustainable framework for long-term investment in generic medicines
▪President Donald Trump announced that imported generic drugs will face a 0% tariff starting August 1, 2026, for two years, rising to 100% in August 2028 and 200% in August 2029

People involved

Donald Trump

Subtopics

Drug Pricing and Access1 Protectionism vs free trade1 Public healthcare1 Tariffs & trade wars1 U.S. domestic politics1

Related timelines